These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15883289)

  • 21. Lessons learnt from the multicentre randomized trials of tacrolimus in liver transplantation.
    Soin AS; Jamieson NV
    Natl Med J India; 1996; 9(5):224-6. PubMed ID: 8937063
    [No Abstract]   [Full Text] [Related]  

  • 22. Posterior leucoencephalopathy syndrome.
    Pullicino P; Zimmer W; Kwen PL
    Lancet; 1996 Jun; 347(9014):1557. PubMed ID: 8684128
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus: effects and side effects.
    Green MD; Michaels MG
    Pediatr Infect Dis J; 1999 Apr; 18(4):372-3. PubMed ID: 10223694
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
    Jardine AG
    Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of pancreas transplants to FK 506 from CsA.
    Tesi RJ; Bryer-Ash M; Jaspan J; Byer-Ashe M [corrected to Bryer-Ash M]
    Transplant Proc; 1995 Dec; 27(6):3032-3. PubMed ID: 8539828
    [No Abstract]   [Full Text] [Related]  

  • 29. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
    Lasocki A; Vote B; Fassett R; Zamir E
    Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of tacrolimus treatment in immune posterior uveitis.
    Figueroa MS; Ciancas E; Orte L
    Eur J Ophthalmol; 2007; 17(1):69-74. PubMed ID: 17294385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 32. [Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?].
    Petrides AS
    Z Gastroenterol; 1995 Jul; 33(7):414-5. PubMed ID: 7571761
    [No Abstract]   [Full Text] [Related]  

  • 33. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis.
    Lee RW; Greenwood R; Taylor H; Amer R; Biester S; Heissigerova J; Forrester JV; Dick AD
    Ophthalmology; 2012 Jun; 119(6):1223-30. PubMed ID: 22381809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of cyclosporine dosage with ketoconazole in a patient with birdshot retinochoroidopathy.
    Nussenblatt RB
    Am J Ophthalmol; 1998 Nov; 126(5):742. PubMed ID: 9822249
    [No Abstract]   [Full Text] [Related]  

  • 36. Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: current concepts and emerging therapeutics.
    Thomas AS; Lin P
    Curr Opin Ophthalmol; 2020 May; 31(3):174-184. PubMed ID: 32168001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V; Griffiths CE
    Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.